company background image
DCAL logo

Dishman Carbogen Amcis NSEI:DCAL Rapport sur les actions

Dernier prix

₹190.65

Capitalisation boursière

₹29.9b

7D

1.4%

1Y

18.4%

Mise à jour

12 Nov, 2024

Données

Finances de l'entreprise

Dishman Carbogen Amcis Limited

NSEI:DCAL Rapport sur les actions

Capitalisation boursière : ₹29.9b

DCAL Aperçu des actions

Dishman Carbogen Amcis Limited fournit des services de recherche et de fabrication sous contrat pour les industries pharmaceutiques, de soins de santé et de biotechnologie dans le monde entier.

DCAL analyse fondamentale
Score flocon de neige
Évaluation2/6
Croissance future0/6
Performances passées0/6
Santé financière2/6
Dividendes0/6

Récompenses

Analyse des risques


Dishman Carbogen Amcis Limited Concurrents

Historique des prix et performances

Résumé des plus hauts, des changements et des baisses de prix pour Dishman Carbogen Amcis
Historique des cours de bourse
Prix actuel de l'action₹190.65
Plus haut sur 52 semaines₹283.00
Plus bas sur 52 semaines₹133.00
Bêta1.24
1Variation sur 1 mois4.31%
Variation sur 3 mois11.08%
Variation sur 1 an18.42%
3Variation sur 3 ans-15.32%
Variation sur 5 ans53.13%
Évolution depuis l'introduction en bourse-45.85%

Nouvelles et mises à jour récentes

The Market Doesn't Like What It Sees From Dishman Carbogen Amcis Limited's (NSE:DCAL) Revenues Yet

Oct 15
The Market Doesn't Like What It Sees From Dishman Carbogen Amcis Limited's (NSE:DCAL) Revenues Yet

Recent updates

The Market Doesn't Like What It Sees From Dishman Carbogen Amcis Limited's (NSE:DCAL) Revenues Yet

Oct 15
The Market Doesn't Like What It Sees From Dishman Carbogen Amcis Limited's (NSE:DCAL) Revenues Yet

Why Investors Shouldn't Be Surprised By Dishman Carbogen Amcis Limited's (NSE:DCAL) 31% Share Price Plunge

Jun 01
Why Investors Shouldn't Be Surprised By Dishman Carbogen Amcis Limited's (NSE:DCAL) 31% Share Price Plunge

Dishman Carbogen Amcis Limited's (NSE:DCAL) Share Price Boosted 29% But Its Business Prospects Need A Lift Too

Feb 25
Dishman Carbogen Amcis Limited's (NSE:DCAL) Share Price Boosted 29% But Its Business Prospects Need A Lift Too

Dishman Carbogen Amcis (NSE:DCAL) Takes On Some Risk With Its Use Of Debt

Dec 29
Dishman Carbogen Amcis (NSE:DCAL) Takes On Some Risk With Its Use Of Debt

Is Dishman Carbogen Amcis (NSE:DCAL) Using Too Much Debt?

Jun 22
Is Dishman Carbogen Amcis (NSE:DCAL) Using Too Much Debt?

Is Dishman Carbogen Amcis (NSE:DCAL) A Risky Investment?

Feb 14
Is Dishman Carbogen Amcis (NSE:DCAL) A Risky Investment?

Dishman Carbogen Amcis (NSE:DCAL) Use Of Debt Could Be Considered Risky

Jun 22
Dishman Carbogen Amcis (NSE:DCAL) Use Of Debt Could Be Considered Risky

Shareholders Will Be Pleased With The Quality of Dishman Carbogen Amcis' (NSE:DCAL) Earnings

May 18
Shareholders Will Be Pleased With The Quality of Dishman Carbogen Amcis' (NSE:DCAL) Earnings

Dishman Carbogen Amcis (NSE:DCAL) Has A Pretty Healthy Balance Sheet

Mar 14
Dishman Carbogen Amcis (NSE:DCAL) Has A Pretty Healthy Balance Sheet

We Think Dishman Carbogen Amcis (NSE:DCAL) Is Taking Some Risk With Its Debt

Aug 23
We Think Dishman Carbogen Amcis (NSE:DCAL) Is Taking Some Risk With Its Debt

Why Dishman Carbogen Amcis Limited (NSE:DCAL) Could Be Worth Watching

Apr 29
Why Dishman Carbogen Amcis Limited (NSE:DCAL) Could Be Worth Watching

Dishman Carbogen Amcis (NSE:DCAL) Has A Somewhat Strained Balance Sheet

Mar 16
Dishman Carbogen Amcis (NSE:DCAL) Has A Somewhat Strained Balance Sheet

A Look At Dishman Carbogen Amcis' (NSE:DCAL) Share Price Returns

Feb 23
A Look At Dishman Carbogen Amcis' (NSE:DCAL) Share Price Returns

How Much Are Dishman Carbogen Amcis Limited (NSE:DCAL) Insiders Spending On Buying Shares?

Feb 05
How Much Are Dishman Carbogen Amcis Limited (NSE:DCAL) Insiders Spending On Buying Shares?

Is Dishman Carbogen Amcis Limited (NSE:DCAL) Popular Amongst Institutions?

Jan 23
Is Dishman Carbogen Amcis Limited (NSE:DCAL) Popular Amongst Institutions?

What We Learned About Dishman Carbogen Amcis' (NSE:DCAL) CEO Compensation

Jan 10
What We Learned About Dishman Carbogen Amcis' (NSE:DCAL) CEO Compensation

Is Now An Opportune Moment To Examine Dishman Carbogen Amcis Limited (NSE:DCAL)?

Dec 23
Is Now An Opportune Moment To Examine Dishman Carbogen Amcis Limited (NSE:DCAL)?

Dishman Carbogen Amcis (NSE:DCAL) Takes On Some Risk With Its Use Of Debt

Dec 05
Dishman Carbogen Amcis (NSE:DCAL) Takes On Some Risk With Its Use Of Debt

Dishman Carbogen Amcis Limited (NSE:DCAL) Shares Could Be 27% Below Their Intrinsic Value Estimate

Nov 17
Dishman Carbogen Amcis Limited (NSE:DCAL) Shares Could Be 27% Below Their Intrinsic Value Estimate

If You Had Bought Dishman Carbogen Amcis' (NSE:DCAL) Shares Three Years Ago You Would Be Down 47%

Oct 23
If You Had Bought Dishman Carbogen Amcis' (NSE:DCAL) Shares Three Years Ago You Would Be Down 47%

What We Learned About Dishman Carbogen Amcis' (NSE:DCAL) CEO Compensation

Sep 27
What We Learned About Dishman Carbogen Amcis' (NSE:DCAL) CEO Compensation

Is Now The Time To Look At Buying Dishman Carbogen Amcis Limited (NSE:DCAL)?

Sep 06
Is Now The Time To Look At Buying Dishman Carbogen Amcis Limited (NSE:DCAL)?

Dishman Carbogen Amcis Limited's (NSE:DCAL) Share Price Could Signal Some Risk

Aug 03
Dishman Carbogen Amcis Limited's (NSE:DCAL) Share Price Could Signal Some Risk

Dishman Carbogen Amcis Limited's (NSE:DCAL) Price In Tune With Earnings

Jul 20
Dishman Carbogen Amcis Limited's (NSE:DCAL) Price In Tune With Earnings

Market Cool On Dishman Carbogen Amcis Limited's (NSE:DCAL) Earnings

Jul 06
Market Cool On Dishman Carbogen Amcis Limited's (NSE:DCAL) Earnings

Rendement pour les actionnaires

DCALIN Life SciencesIN Marché
7D1.4%0.1%0.1%
1Y18.4%56.2%33.4%

Rendement vs Industrie: DCAL a sous-performé le secteur Indian Life Sciences qui a rapporté 56.2 % au cours de l'année écoulée.

Rendement vs marché: DCAL a sous-performé le marché Indian qui a rapporté 33.4 % au cours de l'année écoulée.

Volatilité des prix

Is DCAL's price volatile compared to industry and market?
DCAL volatility
DCAL Average Weekly Movement7.6%
Life Sciences Industry Average Movement6.5%
Market Average Movement6.2%
10% most volatile stocks in IN Market9.2%
10% least volatile stocks in IN Market3.9%

Cours de l'action stable: DCAL n'a pas connu de volatilité de prix significative au cours des 3 derniers mois.

Volatilité au fil du temps: La volatilité hebdomadaire de DCAL ( 8% ) est restée stable au cours de l'année écoulée.

À propos de l'entreprise

FondéeSalariésPDGSite web
19831,132Arpit Vyasimdcal.com

Dishman Carbogen Amcis Limited fournit des services de recherche et de fabrication sous contrat aux industries pharmaceutiques, de santé et de biotechnologie dans le monde entier. La société exerce ses activités par l'intermédiaire des segments Services de recherche et de fabrication sous contrat et Molécules commercialisables. Elle fabrique et fournit également des médicaments en vrac, des ingrédients pharmaceutiques actifs (IPA) et des IPA généraux et très puissants ; des produits chimiques spécialisés comprenant des intermédiaires, des produits chimiques fins, des phosphoranes, des composés d'ammonium quaternaire solides, des réactifs de Wittig et divers produits pharmaceutiques et cosmétiques ; des produits à base de vitamine D et ses analogues ; des produits de lavage des mains et du corps, des désinfectants et des antiseptiques ; et des catalyseurs de transfert de phase, des capsules de gel mou, des formulations désinfectantes, du cholestérol, des produits à base de lanoline et des produits injectables stériles liquides et lyophilisés.

Dishman Carbogen Amcis Limited Résumé des fondamentaux

Comment les bénéfices et les revenus de Dishman Carbogen Amcis se comparent-ils à sa capitalisation boursière ?
DCAL statistiques fondamentales
Capitalisation boursière₹29.89b
Bénéfices(TTM)-₹2.48b
Recettes(TTM)₹24.16b

1.2x

Ratio P/S

-12.1x

Ratio P/E

Le site DCAL est-il surévalué ?

Voir Juste valeur et analyse de l'évaluation

Bénéfices et recettes

Principales statistiques de rentabilité tirées du dernier rapport sur les bénéfices (TTM)
DCAL compte de résultat (TTM)
Recettes₹24.16b
Coût des recettes₹5.05b
Marge brute₹19.11b
Autres dépenses₹21.59b
Les revenus-₹2.48b

Derniers bénéfices déclarés

Jun 30, 2024

Prochaine date de publication des résultats

Nov 13, 2024

Résultat par action (EPS)-15.82
Marge brute79.10%
Marge bénéficiaire nette-10.27%
Ratio dettes/capitaux propres41.1%

Quelles ont été les performances à long terme de DCAL?

Voir les performances historiques et les comparaisons